Suli Pharmaceutical Technology Jiangyin Co., Ltd., a wholly owned subsidiary of Suli Group, was established in 2009, comprising Suli Pharma Shanghai R&D Center, Suli Pharma Jiangyin Production Site, and Dalian Yongda-Suli Pharma. Relying on the company's technical advantages, sufficient production capability and capacity, lean production management, safety, and high-standard GMP quality management, Suli Pharma is committed to providing clients worldwide with APIs, intermediates and CMO/CDMO services featuring stable quality, competitive pricing and excellent service.

暂无评论。
留下您的评分和评论